Lj. Ausubel et al., Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein, CELL IMMUN, 193(1), 1999, pp. 99-107
We have determined that certain altered peptide Ligands (APLs) can induce T
-cells specific for the native peptide myelin basic protein (MBP) p85-99 to
secrete Th2-type cytokines such as IL-4 and IL-5 in the absence of signifi
cant Th1-type cytokines. However, it is not known whether stimulation with
APLs will activate autoreactive T cells or a distinct population of cells.
In the present study, 18 T-cell clones that reacted with either MBP p85-99
or one of three APLs of the peptide substituted at TCR contact residues wer
e generated. T-cells were tested functionally for their reactivity to the o
riginal stimulating peptide as well as to the MBP APLs, In addition, the T-
cell receptor (TCR) alpha and beta chains of each of these clones were sequ
enced. In a series of T-cell clones isolated hom a multiple sclerosis patie
nt, stimulation of T-cells with the APL 93A, which has an alanine for lysin
e substitution at the TCR contact residue 93, did not induce substantial pr
oliferation of MBPp85-99-specific T-cell clones, indicating that a distinct
set of T-cell clones was induced. However, this was not the case for anoth
er set of T-cell clones from a different individual in which the 93A peptid
e induced clonal expansion of T-cells highly reactive with the native MBPp8
5-99 antigen. Thus, the potential beneficial effect of using APLs to induce
downregulatory cytokines appears to depend on the specific T-cell repertoi
re of the individual patient. (C) 1999 Academic Press.